Back

prof. dr. R.E.G. Schutgens

prof. dr. R.E.G. Schutgens

Full Professor
prof. dr. R.E.G. Schutgens
  • Hematology/Van Creveldclinic

Biography

Biography

Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Side Activities

Advisory Board Member Horizonscan geneesmiddelen ZonMW

Scientific Editor HemaSphere (the EHA journal)

Co-owner general practice 'Huisartsenpraktijk Voordorp'

Research Output (245)

The fear for adverse bleeding and cardiovascular events in hemophilia patients using (non-)selective non-steroidal anti-inflammatory drugs:A systematic review reporting on safety

van Bergen E. D.P., Monnikhof M., Lafeber F. P.J.G., Schutgens R. E.G., Mastbergen S. C., van Vulpen L. F.D. 24 Jun 2022, In: Blood Reviews. 56

SYMPHONY consortium:Orchestrating personalized treatment for patients with bleeding disorders

Cnossen Marjon H, van Moort Iris, Reitsma Simone H, de Maat Moniek P M, Schutgens Roger E G, Urbanus Rolf T, Lingsma Hester F, Mathot Ron A A, Gouw Samantha C, Meijer Karina, Bredenoord Annelien L, van der Graaf Rieke, Fijnvandraat Karin, Meijer Alexander B, van den Akker Emile, Bierings Ruben, Eikenboom Jeroen C J, van den Biggelaar Maartje, de Haas Masja, Voorberg Jan, Leebeek Frank W G, 2 Jun 2022, In: Journal of thrombosis and haemostasis : JTH. 20 , p. 2001-2011 11 p.

Proton pump inhibition for secondary hemochromatosis in hereditary anemia:a phase III placebo-controlled randomized cross-over clinical trial.

van Vuren Annelies, Kerkhoffs Jean Louis, Schols Saskia, Rijneveld Anita, Nur Erfan, Peereboom Dore, Gandon Yves, Welsing Paco, van Wijk Richard, Schutgens Roger, van Solinge Wouter, Marx Joannes, Leiner Tim, Biemond Bart, van Beers Eduard 26 Apr 2022, In: American Journal of Hematology. 97 , p. 924-932 9 p.

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

Versloot Olav, Iserman Emma, Chelle Pierre, Germini Federico, Edginton Andrea N, Schutgens Roger E G, Iorio Alfonso, Fischer Kathelijn 21 Apr 2022, In: HemaSphere. 6 , p. 1-7

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease:a phase 2, open-label study

van Dijk Myrthe J, Rab Minke A E, van Oirschot Brigitte A, Bos Jennifer, Derichs Cleo, Rijneveld Anita W, Cnossen Marjon H, Nur Erfan, Biemond Bart J, Bartels Marije, Jans Judith J M, van Solinge Wouter W, Schutgens Roger E G, van Wijk Richard, van Beers Eduard J 5 Apr 2022, In: American Journal of Hematology. 97 , p. E226-E229

Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia

Noordermeer Tessa, van Asten Ivar, Schutgens Roger E.G., Lakerveld Anke J., Koekman Cornelis A., Hage Kay Y., Sebastian Silvie A.E., Huisman Albert, van den Heuvel Dave J., Gerritsen Hans C., Korporaal Suzanne J.A., Bierings Marc, van der Smagt Jasper J., van Gijn Marielle E., Urbanus Rolf T. 7 Mar 2022, In: Blood Advances. 6 , p. 3347-3351 5 p.

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT:To WiN study

Heijdra Jessica M., Al Arashi Wala, De Jager Nico C.B., Cloesmeijer Michael E., Bukkems Laura H., Zwaan Christian M., Leebeek Frank W.G., Mathôt Ron A.A., Cnossen Marjon H., Cnossen M. H., Leebeek F. W.G., Zwaan Christian M., Van Vliet I., Fijnvandraat K., Mathot R. A.A., Meijer K., Kruip M. J.H.A., S Polinder Polinder, Coppens M., Tamminga R. Y.J., Meijer K., Laros-Van B. A.P., Brons P., Schols S. E.M., Van Der Meer F. J.M., Eikenboom H. C.J., Schutgens R. E.G., Fischer K., Heubel-Moenen F., Nieuwenhuizen L., Ypma P., Driessens M. H.E., Pw Collins Collins, Liesner R., Chowdary P., Keeling D. 15 Feb 2022, In: BMJ Open. 12 , p. 1-6

LIVER-RELATED COMPLICATIONS DURING LONG-TERM HEPATITIS C VIRUS INFECTION AND AFTER SUCCESSFUL ANTIVIRAL TREATMENT IN PEOPLE WITH INHERITED BLEEDING DISORDERS

Isfordink C., van Erpecum K., Fischer K., van Vulpen L., Schutgens R., Arends J., Mauser-Bunschoten E. Feb 2022, In: Haemophilia. 28 , p. 18-18

Treatment of patients with rare bleeding disorders in the Netherlands:Real-life data from the RBiN study

Maas Dominique P M S M, Saes Joline L, Blijlevens Nicole M A, Cnossen Marjon H, den Exter Paul L, Kruis Ilmar C, Meijer Karina, Nieuwenhuizen Laurens, Peters Marjolein, Schutgens Roger E G, van Heerde Waander L, Schols Saskia E M, 17 Jan 2022, In: Journal of thrombosis and haemostasis : JTH. 20 , p. 833-844 12 p.

Relapse of immune thrombocytopenia after COVID-19 vaccination

van Dijk Wobke Else Maria, Schutgens Roger E G Jan 2022, In: European Journal of Haematology. 108 , p. 84-85 2 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet